Mangosteen Blood Glucose Meta-analysis: What the Evidence Says

Quick Answer

Mangosteen Blood Glucose Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 systematic review, 1 observational study.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• The number of DM patients has rapidly increased in recent years and is predicted to reach about 643 million people by 2030. [Chatatikun Moragot (2024); evidence level 1]
• Yani et al., 2021 Stone and Rosopa, 2017 Rouse et al., 2017 Nowadays, the consumption of botanical drugs for complementary and alternative medicine has rapidly increased. [Chatatikun Moragot (2024); evidence level 1]
• A study in Thailand found that 13.0% of urban hypertensive patients and 17.5% of rural hypertensive patients utilized herbals. [Widayati Aris (2025); evidence level 3]
• Meanwhile, another study among hypertensive patients in rural areas in Indonesia found that 68.5% of 384 patients used herbal medicines, either alone or in conjunction with prescription medicines. [Widayati Aris (2025); evidence level 3]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For mangosteen blood glucose meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Chatatikun Moragot (2024). Hypoglycemic activity of Garcinia mangostana L. extracts on diabetes rodent models: A systematic review and network meta-analysis. DOI: 10.3389/fphar.2024.1472419. PMCID: PMC11479905. PMID: 39415841. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC11479905/
• Widayati Aris (2025). Factors associated with herbal usage among hypertensive and diabetic patients in Yogyakarta, Indonesia: A cross-sectional study. DOI: 10.1038/s41598-025-31978-z. PMCID: PMC12816713. PMID: 41422134. License: https://creativecommons.org/licenses/by-nc-nd/4.0/ http://creativecommons.org/licenses/by-nc-nd/4.0/ This article is .... https://pmc.ncbi.nlm.nih.gov/articles/PMC12816713/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.